ArticleBritish journal of cancer2018
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit.
Tiziana Triulzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it